NCT06504082View on ClinicalTrials.gov

Comparison of the Effectiveness of Single-Dose Methotrexate Protocol With Letrozole + Single-Dose Methotrexate in the Medical Treatment of Patients Diagnosed With Ectopic Pregnancy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

September 5, 2022

Study Completion Date

September 5, 2022

Conditions
Ectopic Pregnancy
Interventions
DRUG

Letrozole

Patients in the MTX + letrozole group received letrozole tablets (Femara 2.5 mg) once daily for ten days starting from the day of MTX administration.

DRUG

Methotrexate

After confirming the diagnosis of tubal ectopic pregnancy, each patient will receive a single dose of intramuscular MTX (50 mg/m² MTX) on the same day

Trial Locations (1)

06145

Yuzuncu Yil University, Van

All Listed Sponsors
lead

Yuzuncu Yıl University

OTHER

NCT06504082 - Comparison of the Effectiveness of Single-Dose Methotrexate Protocol With Letrozole + Single-Dose Methotrexate in the Medical Treatment of Patients Diagnosed With Ectopic Pregnancy | Biotech Hunter | Biotech Hunter